NextCure (NXTC) Common Equity (2018 - 2026)
NextCure's Common Equity came in at $12.15 million for Q2 2026, down 59.0% from $29.65 million a year earlier and down 54.5% from the prior quarter.
Powered by 
Analysis
NextCure (NXTC) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, NextCure's Common Equity was $34.94 million, down 46.6% from FY2024.
- Common Equity has declined in each of the last six years, with a five-year compound annual growth rate of -34.7% (FY2020 to FY2025).
- Going back by year, Common Equity was $65.47 million in FY2024 (-42.8%), $114.42 million in FY2023 (-31.7%), $167.53 million in FY2022 (-28.2%) and $233.39 million in FY2021 (-20.5%).
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q1 2019.
- Year-over-year, Common Equity has declined for 23 consecutive quarters, with an average decline of 52.3% over the last eight quarters.
- The year-over-year decline in Common Equity has ranged between 19.2% (Q3 2021) and 68.7% (Q3 2025) over the last five years.
- Business Quant data shows NXTC's Common Equity at $26.72 million (Q1 2026), $34.94 million (Q4 2025) and $23.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.90 Bn | 1,102.48 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 616.46 Bn | 534.99 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 501.26 Bn | 474.37 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 367.00 Bn | 321.38 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.91 Bn | 261.90 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.82 Bn | 191.22 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 190.63 Bn | 164.82 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 85.49 Bn |
| 10 | NextCure | 29.89 Mn | -90.87 Mn | - | 12.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.15 Mn |
| Mar 31, 2026 | 26.72 Mn |
| Dec 31, 2025 | 34.94 Mn |
| Sep 30, 2025 | 23.65 Mn |
| Jun 30, 2025 | 29.65 Mn |
| Mar 31, 2025 | 55.86 Mn |
| Dec 31, 2024 | 65.47 Mn |
| Sep 30, 2024 | 75.59 Mn |
| Jun 30, 2024 | 85.44 Mn |
| Mar 31, 2024 | 99.05 Mn |
| Dec 31, 2023 | 114.42 Mn |
| Sep 30, 2023 | 126.45 Mn |
| Jun 30, 2023 | 138.43 Mn |
| Mar 31, 2023 | 154.20 Mn |
| Dec 31, 2022 | 167.53 Mn |
| Sep 30, 2022 | 181.54 Mn |
| Jun 30, 2022 | 198.20 Mn |
| Mar 31, 2022 | 213.94 Mn |
| Dec 31, 2021 | 233.39 Mn |
| Sep 30, 2021 | 248.23 Mn |
API Access
NextCure Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();